Acelya Yilmazer, PhD - Publications

2007-2008 School of Pharmacy University of Nottingham, Nottingham, England, United Kingdom 
 2008-2013 School of Pharmacy University of London, London, England, United Kingdom 
 2013- Engineering Faculty, Biomedical Engineering Department Ankara University 
liposome, drug delivery, regenerative medicine

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Casajus Pelegay E, Puzzo F, Yilmazer A, Cagin U. Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases. Advances in Experimental Medicine and Biology. 1134: 89-110. PMID 30919333 DOI: 10.1007/978-3-030-12668-1_5  0.52
2019 Taheri H, Cagin U, Yilmazer A. Reprogramming of Human Melanocytes and Melanoma Cells with Yamanaka Factors. Methods in Molecular Biology (Clifton, N.J.). 1916: 249-261. PMID 30535702 DOI: 10.1007/978-1-4939-8994-2_24  1
2018 de Lázaro I, Yilmazer A, Nam Y, Qubisi S, Razak FMA, Degens H, Cossu G, Kostarelos K. Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30470628 DOI: 10.1016/j.ymthe.2018.10.014  1
2018 Aydin T, Gurcan C, Taheri H, Yilmazer A. Graphene Based Materials in Neural Tissue Regeneration. Advances in Experimental Medicine and Biology. PMID 29882208 DOI: 10.1007/5584_2018_221  1
2018 Yener Ilce B, Cagin U, Yilmazer A. Cellular reprogramming: A new way to understand aging mechanisms. Wiley Interdisciplinary Reviews. Developmental Biology. 7. PMID 29350802 DOI: 10.1002/wdev.308  0.52
2015 Yilmazer A, de Lázaro I, Taheri H. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling? Cancer Letters. 369: 1-8. PMID 26276716 DOI: 10.1016/j.canlet.2015.06.027  1
2014 Yilmazer A, Tian B, Kostarelos K. Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers. Plos One. 9: e114985. PMID 25501573 DOI: 10.1371/journal.pone.0114985  1
2014 de Lázaro I, Bussy C, Yilmazer A, Jackson MS, Humphreys NE, Kostarelos K. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells. Biomaterials. 35: 8312-20. PMID 25002261 DOI: 10.1016/j.biomaterials.2014.05.086  1
2014 de Lázaro I, Yilmazer A, Kostarelos K. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics? Journal of Controlled Release : Official Journal of the Controlled Release Society. 185: 37-44. PMID 24746625 DOI: 10.1016/j.jconrel.2014.04.011  1
2013 Yilmazer A, de Lázaro I, Bussy C, Kostarelos K. In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors. Journal of Visualized Experiments : Jove. e50837. PMID 24378537 DOI: 10.3791/50837  1
2013 Yilmazer A, de Lázaro I, Bussy C, Kostarelos K. In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors. Plos One. 8: e54754. PMID 23355895 DOI: 10.1371/journal.pone.0054754  1
2013 Yilmazer A, Al-Jamal WT, Van den Bossche J, Kostarelos K. The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity. Biomaterials. 34: 1354-63. PMID 23146432 DOI: 10.1016/j.biomaterials.2012.10.053  1
2011 Van den Bossche J, Al-Jamal WT, Yilmazer A, Bizzarri E, Tian B, Kostarelos K. Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials. 32: 3085-93. PMID 21269689 DOI: 10.1016/j.biomaterials.2010.12.043  1
2010 Al-Jamal KT, Toma FM, Yilmazer A, Ali-Boucetta H, Nunes A, Herrero MA, Tian B, Eddaoudi A, Eddaoui A, Al-Jamal WT, Bianco A, Prato M, Kostarelo K. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 4354-65. PMID 20647548 DOI: 10.1096/fj.09-141036  1
2010 Al-Jamal KT, Al-Jamal WT, Akerman S, Podesta JE, Yilmazer A, Turton JA, Bianco A, Vargesson N, Kanthou C, Florence AT, Tozer GM, Kostarelos K. Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth Proceedings of the National Academy of Sciences of the United States of America. 107: 3966-3971. PMID 20150514 DOI: 10.1073/pnas.0908401107  0.36
Show low-probability matches.